DEC 02, 2021 8:00 AM PST

New mRNA Vaccine Stops Ticks, Prevents Lyme Disease

WRITTEN BY: Tara Fernandez

Yale University researchers have developed an mRNA vaccine against ticks that could help prevent Lyme disease. This is a debilitating chronic condition caused by the bacteria Borrelia burgdorferi, which enters the body through the bite of infected black-legged ticks. If not promptly treated, the infection can spread to the joints, nervous system, and the heart, causing a lifetime of severe health issues.

Researcher Erol Fikrig led a team that created the blueprints for the experimental Lyme disease vaccine called 19ISP, which trains the immune system to identify a panel of 19 proteins found in the saliva of ticks. The research is featured in the journal Science Translational Medicine.

Fikrig and colleagues then tested their vaccine in a guinea pig model of Lyme disease. When vaccinated animals were bitten by ticks, they developed itchy hives, which was a clear sign that the immune systems were responding to the tick salivary proteins. Interestingly, ticks detached from the skin of vaccinated animals much faster—a good thing, considering that it takes about 36 hours for ticks to transmit the Lyme disease-causing bacteria.

Promisingly, none of the vaccinated animals bitten by infected ticks developed Lyme disease, whereas half the unvaccinated animals did.

Fikrig predicts that the mRNA vaccine will have a similar mode of action in humans, causing redness and itching at the bite site, providing a red flag that a tick has latched on to the skin. Presently, tick bites often go unnoticed, as the bites are painless. Even without removing the tick, the immune response triggered by the vaccine should cause the tick to naturally detach before it gets a chance to transmit the pathogenic bacteria.

19ISP is not the only Lyme disease vaccine currently in development, but it’s the first to target tick salivary proteins (and not the Lyme disease-causing bacteria itself). One benefit of this novel approach is that it may also help shield against other tick-borne diseases such as anaplasmosis and babesiosis.

Estimates say that around 476,000 people are diagnosed and treated for Lyme disease in the United States. In the absence of a vaccine, health authorities suggest that reducing exposure to ticks is the best defense against Lyme disease. This includes avoiding areas with high grasses or bushes and keeping pets and yards tick-free.



 

About the Author
  • Tara Fernandez has a PhD in Cell Biology and has spent over a decade uncovering the molecular basis of diseases ranging from skin cancer to obesity and diabetes. She currently works on developing and marketing disruptive new technologies in the biotechnology industry. Her areas of interest include innovation in molecular diagnostics, cell therapies, and immunology. She actively participates in various science communication and public engagement initiatives to promote STEM in the community.
You May Also Like
OCT 19, 2021
Drug Discovery & Development
Researchers develop a potent antiviral drug for dengue fever
OCT 19, 2021
Researchers develop a potent antiviral drug for dengue fever
Dengue fever is a mosquito borne illness that is widespread, especially in tropical countries. The global incidence of d ...
DEC 09, 2021
Cancer
Inflammation: Naughty or Nice List?
DEC 09, 2021
Inflammation: Naughty or Nice List?
Aulus Cornelius Celsus, a Roman physician, first identified the four major characteristics of inflammation in the first ...
DEC 23, 2021
Immunology
Hitting the Anti-inflammatory Bullseye to Treat IBD
DEC 23, 2021
Hitting the Anti-inflammatory Bullseye to Treat IBD
Fifty percent—that’s the percentage of patients with inflammatory bowel disease (IBD) who experience long-te ...
JAN 06, 2022
Health & Medicine
New Hope for Hair Regrowth in Alopecia Areata
JAN 06, 2022
New Hope for Hair Regrowth in Alopecia Areata
Two recently completed phase 3 clinical trials showed the drug baricitinib leads to hair growth for alopecia areata pati ...
JAN 14, 2022
Drug Discovery & Development
Repurposing Drugs 101
JAN 14, 2022
Repurposing Drugs 101
Drug development is expensive. Taking into account costs of failed trials, the average drug costs $985 million to resear ...
JAN 18, 2022
Immunology
Omicron Can't Dodge T Cells
JAN 18, 2022
Omicron Can't Dodge T Cells
The Omicron variant was first reported in November 2021. More recently, a surge of infections worldwide has led to wides ...
Loading Comments...